Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects von Pathak, A., Lebrin, M., Vaccaro, A., Senard, J. M., Despas, F.

Volltext

Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects von Hijona, E., Aguirre, L., Pérez-Matute, P., Villanueva-Millán, M. J., Mosqueda-Solis, A., Hasnaoui, M., Nepveu, F., Senard, J. M., Bujanda, L., Aldámiz-Echevarría, L., Llarena, M., Andrade, F., Perio, P., Leboulanger, F., Hijona, L., Arbones-Mainar, J. M., Portillo, M.P., Carpéné, C.

Volltext

Neurogenic orthostatic hypotension of Parkinson's disease: What exploration for what treatment? von Senard, J.-M., Pathak, A.

Volltext

The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men von Galitzky, J, Sengenès, C, Thalamas, C, Marques, M A, Senard, J M, Lafontan, M, Berlan, M

Volltext

Treatment of Parkinson's disease should begin with a dopamine agonist von Montastruc, Jean Louis, Rascol, Olivier, Senard, Jean-Michel

Volltext

L’activation du baroréflexe par stimulation implantable du sinus carotidien dans le traitement de l’hypertension artérielle résistante von Pathak, A., Labrunee, M., Vaccaro, A., Della Rosa, F., Guiraud, T., Pavy Le Traon, A., Galinier, M., Senard, J.-M.

Volltext

P1.14 Excessive sympathetic activation in heart failure with chronic renal failure: Role of chemoreflex activation von Despas, F, Detis, N, Franchitto, N, Galinier, M, Senard, J.-M, Pathak, A

Volltext

Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease von RASCOL, O, LEES, A. J, SENARD, J. M, PIRTOSEK, Z, MONTASTRUC, J. L, FUELL, D

Volltext

Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa von Rascol, O, Sabatini, U, Chollet, F, Fabre, N, Senard, J M, Montastruc, J L, Celsis, P, Marc-Vergnes, J P, Rascol, A

Volltext

Insulin downregulates M2-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications von PATHAK, A, SMIH, F, GALINIER, M, VERWAERDE, P, ROUET, P, PHILIP-COUDERC, P, MONTASTRUC, J. L, SENARD, J. M

Volltext

Medication error caused by confusing drug blisters von Pathak, A, Senard, JM, Bujaud, T, Bagheri, H, Lapeyre-Mestre, M, Tressieres, MC, Montastruc, JL

Volltext

Current status of dopamine agonists in Parkinson's disease management von MONTASTRUC, J. L, RASCOL, O, SENARD, J. M

Volltext

A study of tolerance to apomorphine von Montastruc, Jean‐Louis, Llau, Marie‐Elise, Senard, Jean‐Michel, Tran, Marie‐Antoinette, Rascol, Olivier, Montastruc, Paul

Volltext

Visual hallucinations at the onset of tolterodine treatment in a patient with a high‐level spinal cord injury von MALAVAUD, B, BAGHERI, H, SENARD, J. M, SARRAMON, J. P

Volltext

Glutamate antagonists and Parkinson's disease: A review of clinical data von Montastruc, J.L., Rascol, O., Senard, J.M.

Volltext

Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease von Rascol, Olivier, Fabre, Nelly, Blin, Olivier, Poulik, Janet, Sabatini, Umberto, Senard, Jean-Michel, Ané, Michèle, Montastruc, Jean-Louis, Rascol, André

Volltext

Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy von Senard, J M, Rascol, O, Durrieu, G, Tran, M A, Berlan, M, Rascol, A, Montastruc, J L

Volltext

Chronic pain in Parkinson's disease: The cross-sectional French DoPaMiP survey von Nègre-Pagès, Laurence, Regragui, Wafa, Bouhassira, Didier, Grandjean, Héléne, Rascol, Olivier

Volltext

L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple syst... von Mathias, C J, Senard, J M, Braune, S, Watson, L, Aragishi, A, Keeling, J E, Taylor, M D

Volltext

Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy von Rascol, Olivier, Sieradzan, Kasia, Peyro-Saint-Paul, Hélène, Thalamas, Claire, Brefel-Courbon, Christine, Senard, Jean Michel, Ladure, Philippe, Montastruc, Jean Louis, Lees, Andrew

Volltext